Cargando…
Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939851/ https://www.ncbi.nlm.nih.gov/pubmed/36805385 http://dx.doi.org/10.1007/s10147-023-02310-4 |
| _version_ | 1784890953197158400 |
|---|---|
| author | Caruso, Teresita Salani, Francesca Catanese, Silvia Pratesi, Federico Mercinelli, Chiara Motta, Giuseppe Genovesi, Virginia Bonato, Adele Sara, Galimberti Masi, Gianluca Migliorini, Paola |
| author_facet | Caruso, Teresita Salani, Francesca Catanese, Silvia Pratesi, Federico Mercinelli, Chiara Motta, Giuseppe Genovesi, Virginia Bonato, Adele Sara, Galimberti Masi, Gianluca Migliorini, Paola |
| author_sort | Caruso, Teresita |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9939851 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Nature Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99398512023-02-21 Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies Caruso, Teresita Salani, Francesca Catanese, Silvia Pratesi, Federico Mercinelli, Chiara Motta, Giuseppe Genovesi, Virginia Bonato, Adele Sara, Galimberti Masi, Gianluca Migliorini, Paola Int J Clin Oncol Correction Springer Nature Singapore 2023-02-20 2023 /pmc/articles/PMC9939851/ /pubmed/36805385 http://dx.doi.org/10.1007/s10147-023-02310-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Caruso, Teresita Salani, Francesca Catanese, Silvia Pratesi, Federico Mercinelli, Chiara Motta, Giuseppe Genovesi, Virginia Bonato, Adele Sara, Galimberti Masi, Gianluca Migliorini, Paola Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies |
| title | Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies |
| title_full | Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies |
| title_fullStr | Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies |
| title_full_unstemmed | Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies |
| title_short | Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies |
| title_sort | correction to: repeated sars-cov-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-rbd neutralizing antibodies |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939851/ https://www.ncbi.nlm.nih.gov/pubmed/36805385 http://dx.doi.org/10.1007/s10147-023-02310-4 |
| work_keys_str_mv | AT carusoteresita correctiontorepeatedsarscov2vaccinationincancerpatientstreatedwithimmunecheckpointinhibitorsinductionofhighavidityantirbdneutralizingantibodies AT salanifrancesca correctiontorepeatedsarscov2vaccinationincancerpatientstreatedwithimmunecheckpointinhibitorsinductionofhighavidityantirbdneutralizingantibodies AT catanesesilvia correctiontorepeatedsarscov2vaccinationincancerpatientstreatedwithimmunecheckpointinhibitorsinductionofhighavidityantirbdneutralizingantibodies AT pratesifederico correctiontorepeatedsarscov2vaccinationincancerpatientstreatedwithimmunecheckpointinhibitorsinductionofhighavidityantirbdneutralizingantibodies AT mercinellichiara correctiontorepeatedsarscov2vaccinationincancerpatientstreatedwithimmunecheckpointinhibitorsinductionofhighavidityantirbdneutralizingantibodies AT mottagiuseppe correctiontorepeatedsarscov2vaccinationincancerpatientstreatedwithimmunecheckpointinhibitorsinductionofhighavidityantirbdneutralizingantibodies AT genovesivirginia correctiontorepeatedsarscov2vaccinationincancerpatientstreatedwithimmunecheckpointinhibitorsinductionofhighavidityantirbdneutralizingantibodies AT bonatoadele correctiontorepeatedsarscov2vaccinationincancerpatientstreatedwithimmunecheckpointinhibitorsinductionofhighavidityantirbdneutralizingantibodies AT saragalimberti correctiontorepeatedsarscov2vaccinationincancerpatientstreatedwithimmunecheckpointinhibitorsinductionofhighavidityantirbdneutralizingantibodies AT masigianluca correctiontorepeatedsarscov2vaccinationincancerpatientstreatedwithimmunecheckpointinhibitorsinductionofhighavidityantirbdneutralizingantibodies AT migliorinipaola correctiontorepeatedsarscov2vaccinationincancerpatientstreatedwithimmunecheckpointinhibitorsinductionofhighavidityantirbdneutralizingantibodies |